- Home
- PCVX vs SLG Comparison
PCVX vs SLG Comparison
Compare PCVX & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | SLG |
|---|---|---|
| Founded | 2013 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 3.4B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PCVX | SLG |
|---|---|---|
| Price | $46.57 | $42.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 15 |
| Target Price | ★ $101.67 | $62.33 |
| AVG Volume (30 Days) | ★ 1.5M | 1.4M |
| Earning Date | 11-04-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 7.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $661,814,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.66 | $40.26 |
| 52 Week High | $94.60 | $79.22 |
Technical Indicators
Market Signals| Indicator | PCVX | SLG |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 29.78 |
| Support Level | $43.78 | $46.15 |
| Resistance Level | $48.11 | $47.67 |
| Average True Range (ATR) | 1.99 | 1.92 |
| MACD | -0.49 | 0.05 |
| Stochastic Oscillator | 42.99 | 29.71 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.